Trademarkia Logo

Canada

C$
FELIOME
REGISTERED

on 1 Feb 2023

Last Applicant/ Owned by

EXEGI PHARMA LLC

90 Church StreetRockville, MD 20850

US

Serial Number

2021039 filed on 3rd Apr 2020

Registration Number

TMA1163177 registered on 1st Feb 2023

Registration expiry Date

1st Feb 2033

Correspondent Address

WILSON LUE LLP

150 York Street, Suite 400Toronto

ONTARIO

CA

M5H3S5

FELIOME

Trademark usage description

food supplements for the treatment of inflammatory bowel diseases, ulcerative colitis, irritable bowel syndrome, pouchitis, liver disease; food supple Read More

Classification Information


Class [005]
Food supplements for the treatment of inflammatory bowel diseases, ulcerative colitis, irritable bowel syndrome, pouchitis, liver disease; Food supplements for animals for treating digestive disorders; Health food supplements for animals for the treatment of inflammatory bowel diseases, ulcerative colitis, irritable bowel syndrome, pouchitis, liver disease; Nutritional supplements, namely, probiotic compositions for animals; Dietary and nutritional supplements for animals for the treatment of inflammatory bowel diseases, ulcerative colitis, irritable bowel syndrome, pouchitis, liver disease; Live biotherapeutics for animals for the treatment of inflammatory bowel diseases, ulcerative colitis, irritable bowel syndrome, pouchitis, liver diseases; Medical Food, namely, dietetic foods for animals in the nature of powder specially adapted for medical use for the treatment of inflammatory bowel diseases, ulcerative colitis, irritable bowel syndrome, pouchitis, liver disease; Probiotic supplements for animals.


Classification kind code

11

Mark Details


Serial Number

2021039

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 190
on 1st Feb 2023
Registration Pending
Submitted for opposition 55
on 1st Feb 2023
Registered
Submitted for opposition 42
on 9th Nov 2022
Advertised
Submitted for opposition 26
on 12th Oct 2022
Approved
Submitted for opposition 27
on 12th Oct 2022
Approval Notice Sent
Submitted for opposition 22
on 3rd Mar 2022
Search Recorded
Submitted for opposition 20
on 3rd Mar 2022
Examiner's First Report
Submitted for opposition 30
on 3rd Apr 2020
Filed
Submitted for opposition 1
on 3rd Apr 2020
Created
Submitted for opposition 31
on 3rd Apr 2020
Formalized